Zebra Technologies Corporation

(NASDAQ Global Select)
Bullish +55

Zebra Technologies Corporation $ZBRA Shares Acquired by Calamos ...

📈 Calamos Advisors increased its ZBRA stake by 7.2% in Q1, adding 2,982 shares to reach a total holding of 44,488 shares valued at $9.3 million.

🏦 Multiple institutional investors including Brown Advisory, New York Life, and M&T Bank increased their holdings in the second or fourth quarters.

📉 Insider Melissa Luff sold 500 shares for $126,975, while Director Janice Roberts sold 3,000 shares for $748,620, reducing their respective ownership percentages.

💰 Zebra Technologies reported Q2 EPS of $4.75, surpassing analyst estimates of $4.21 by $0.54.

📊 Revenue reached $1.50 billion, representing a 14.3% increase compared to the same quarter last year.

🎯 The company achieved a return on equity of 18.91% and a net margin of 7.49% for the reported quarter.

🔮 FY 2026 EPS guidance is set between $18.30 and $18.70, with Q2 2026 guidance ranging from $4.20 to $4.50.

📈 Analyst consensus rating is 'Moderate Buy' with a collective price target of $327.00.

🏆 Citigroup raised its price target to $306.00 and Robert W. Baird increased its target to $310.00.

📉 Northcoast Research lowered its price objective to $344.00 but maintained a 'Buy' rating.

🏢 Institutional ownership stands at 91.03%, indicating strong confidence from large asset managers.

👥 Company insiders collectively own 0.91% of the outstanding shares following recent sales.

Bullish Signals
  • Zebra Technologies beat quarterly earnings estimates with EPS of $4.75 versus consensus of $4.21, demonstrating strong operational performance.
  • Revenue grew 14.3% year-over-year to $1.50 billion, indicating robust demand for the company's industrial products and solutions.
  • The company maintains healthy profitability metrics with a net margin of 7.49% and a return on equity of 18.91%.
  • Major institutional investors like Calamos Advisors increased their stakes, signaling confidence in the company's long-term prospects.
  • Analyst consensus is 'Moderate Buy' with a price target of $327.00, supported by multiple upgrades and target price increases from firms like Citigroup and Robert W. Baird.
  • The company has set clear growth guidance for FY 2026 (EPS $18.30-$18.70) and Q2 2026 (EPS $4.20-$4.50), providing visibility for investors.
Risk Factors
  • Insider selling activity, including a 32.67% reduction in Director Janice Roberts' holdings, may indicate reduced personal confidence or liquidity needs.
  • Northcoast Research lowered its price objective from $364.00 to $344.00, suggesting some analysts see limited upside potential at current levels.
Full Analysis
Calamos Advisors LLC increased its stake in Zebra Technologies Corporation (NASDAQ:ZBRA) by 7.2% during the first quarter, purchasing an additional 2,982 shares to own a total of 44,488 shares valued at approximately $9.3 million. Several other institutional investors, including Brown Advisory Inc., Empowered Funds LLC, New York Life Investment Management LLC, Gulf International Bank UK Ltd, and M&T Bank Corp, also boosted their positions in the second or fourth quarters, collectively driving institutional ownership to 91.03%. In insider trading activity, Melissa Luff sold 500 shares at an average price of $253.95, reducing her holdings by 11.90%, while Director Janice M. Roberts sold 3,000 shares at $249.54, decreasing her position by 32.67%. Following these transactions, insiders collectively own 0.91% of the company's stock. Zebra Technologies reported strong financial results for the quarter ended May 12th, with earnings per share (EPS) of $4.75, beating analyst estimates of $4.21. The company generated revenue of $1.50 billion, a 14.3% year-over-year increase, and achieved a net margin of 7.49%. Analysts have set FY 2026 guidance between $18.30 and $18.70 EPS, with the current consensus target at $15.20. Wall Street sentiment remains largely positive with eight analysts rating the stock as a Buy and five as Hold. Recent price targets include Citigroup raising its target to $306.00 and Robert W. Baird boosting its target to $310.00, while Northcoast Research lowered its objective to $344.00 but maintained a Buy rating. The consensus price target stands at $327.00.